H. Jack

Learn More
PURPOSE Maintaining target hemoglobin (Hb) with minimal variability is a challenge in hemodialysis (HD) patients. The aim of this study is to compare the long- and short-acting erythropoietin-stimulating agents such as Aranesp and Eprex in achieving these targets. METHODS Randomized, prospective, open-labeled study of 24 weeks includes stable patients on(More)
  • 1